Compare Pfizer with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs PANACEA BIOTECH - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER PANACEA BIOTECH PFIZER/
PANACEA BIOTECH
 
P/E (TTM) x 48.8 15.8 307.9% View Chart
P/BV x 8.1 6.2 131.3% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 PFIZER   PANACEA BIOTECH
EQUITY SHARE DATA
    PFIZER
Mar-19
PANACEA BIOTECH
Mar-19
PFIZER/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs3,840354 1,086.0%   
Low Rs2,080138 1,505.1%   
Sales per share (Unadj.) Rs455.074.6 610.2%  
Earnings per share (Unadj.) Rs93.86.7 1,404.1%  
Cash flow per share (Unadj.) Rs109.415.5 705.9%  
Dividends per share (Unadj.) Rs22.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs658.257.2 1,150.6%  
Shares outstanding (eoy) m45.7561.25 74.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.53.3 197.3%   
Avg P/E ratio x31.636.8 85.7%  
P/CF ratio (eoy) x27.115.9 170.5%  
Price / Book Value ratio x4.54.3 104.6%  
Dividend payout %24.00-   
Avg Mkt Cap Rs m135,42015,061 899.1%   
No. of employees `0002.62.3 113.7%   
Total wages/salary Rs m3,2381,471 220.2%   
Avg. sales/employee Rs Th7,911.41,973.6 400.9%   
Avg. wages/employee Rs Th1,230.9635.6 193.7%   
Avg. net profit/employee Rs Th1,630.7176.8 922.4%   
INCOME DATA
Net Sales Rs m20,8154,567 455.8%  
Other income Rs m1,67445 3,736.4%   
Total revenues Rs m22,4894,612 487.6%   
Gross profit Rs m5,7122,030 281.4%  
Depreciation Rs m714540 132.2%   
Interest Rs m731,048 7.0%   
Profit before tax Rs m6,599486 1,357.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,30977 2,994.3%   
Profit after tax Rs m4,291409 1,048.8%  
Gross profit margin %27.444.4 61.7%  
Effective tax rate %35.015.9 220.6%   
Net profit margin %20.69.0 230.1%  
BALANCE SHEET DATA
Current assets Rs m27,1672,415 1,125.1%   
Current liabilities Rs m8,9179,077 98.2%   
Net working cap to sales %87.7-145.9 -60.1%  
Current ratio x3.00.3 1,145.4%  
Inventory Days Days6865 104.2%  
Debtors Days Days3071 42.4%  
Net fixed assets Rs m8,8628,333 106.3%   
Share capital Rs m45861 746.3%   
"Free" reserves Rs m29,6563,443 861.4%   
Net worth Rs m30,1133,504 859.4%   
Long term debt Rs m25461 5.4%   
Total assets Rs m39,40013,755 286.4%  
Interest coverage x91.51.5 6,252.4%   
Debt to equity ratio x00.1 0.6%  
Sales to assets ratio x0.50.3 159.1%   
Return on assets %11.110.6 104.5%  
Return on equity %14.211.7 122.0%  
Return on capital %22.138.7 57.2%  
Exports to sales %020.9 0.0%   
Imports to sales %08.1 0.0%   
Exports (fob) Rs mNA954 0.0%   
Imports (cif) Rs mNA372 0.0%   
Fx inflow Rs m4281,203 35.6%   
Fx outflow Rs m786467 168.5%   
Net fx Rs m-358736 -48.6%   
CASH FLOW
From Operations Rs m9781,049 93.3%  
From Investments Rs m351-54 -656.4%  
From Financial Activity Rs m-1,099-1,011 108.6%  
Net Cashflow Rs m231-20 -1,171.6%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 0.6 1,250.0%  
FIIs % 4.9 1.3 376.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 23.6 100.4%  
Shareholders   85,207 10,259 830.6%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  NATCO PHARMA  ELDER PHARMA  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


May 7, 2021 (Close)

TRACK PFIZER

PFIZER - GSK PHARMA COMPARISON

COMPARE PFIZER WITH

MARKET STATS